Skip to main content

Featured

Ukrainian Strike Targets Key Russian Missile Facility in Deep-Range Operation

    An employee controls an unmanned ground vehicle during an exhibition of Ukrainian drone makers, amid Russia's attack on Ukraine, in an undisclosed location Ukraine says it carried out a long‑range strike against a major Russian ballistic missile production site, marking one of Kyiv’s deepest attacks inside Russian territory since the full‑scale invasion began. According to Ukrainian security officials, the operation targeted a facility involved in manufacturing components for Russia’s Iskander missile systems—munitions frequently used against Ukrainian cities. While Moscow has not confirmed the strike, Russian regional authorities reported explosions and a subsequent fire at an industrial site. Kyiv has increasingly relied on domestically produced long‑range drones and missiles as Western military aid faces delays, and Ukrainian officials framed the attack as part of a broader effort to degrade Russia’s ability to wage war. The strike underscores Ukraine’s evolving stra...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment